The chemical substance known as (2R,3R)-2-(2,4-Difluorophenyl)-3-((tetrahydro-2H-pyran-2-yl)oxy)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, with the CAS number 135133-23-2, is characterized by its complex molecular structure, which includes multiple functional groups. It features a butanol backbone with stereocenters at the 2 and 3 positions, indicating chirality. The presence of a difluorophenyl group suggests potential for significant biological activity, as fluorinated compounds often exhibit enhanced lipophilicity and metabolic stability. Additionally, the tetrahydro-2H-pyran moiety contributes to the compound's overall hydrophobic character, while the triazole ring may impart specific interactions with biological targets, making it of interest in medicinal chemistry. The compound's solubility, stability, and reactivity are influenced by these structural elements, which can affect its pharmacokinetic properties. Overall, this substance is likely to be studied for its potential applications in pharmaceuticals, particularly in the development of therapeutic agents.

(2R,3R)-2-(2,4-Difluorophenyl)-3-((tetrahydro-2H-pyran-2-yl)oxy)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

135133-23-2: The chemical substance known as (2R,3R)-2-(2,4-Difluorophenyl)-3-((tetrahydro-2H-pyran-2-yl)oxy)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, with the CAS number 135133-23-2, is characterized by its complex molecular structure, which includes multiple functional groups. It features a butanol backbone with stereocenters at the 2 and 3 positions, indicating chirality. The presence of a difluorophenyl group suggests potential for significant biological activity, as fluorinated compounds often exhibit enhanced lipophilicity and metabolic stability. Additionally, the tetrahydro-2H-pyran moiety contributes to the compound's overall hydrophobic character, while the triazole ring may impart specific interactions with biological targets, making it of interest in medicinal chemistry. The compound's solubility, stability, and reactivity are influenced by these structural elements, which can affect its pharmacokinetic properties. Overall, this substance is likely to be studied for its potential applications in pharmaceuticals, particularly in the development of therapeutic agents.

CAS 135133-23-2

(2R,3R)-2-(2,4-Difluorophenyl)-3-((tetrahydro-2H-pyran-2-yl)oxy)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

Efinaconazole Impurity 28

Ref: 4Z-E-097038

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol 3-THP Ether

Ref: TR-D451373

Efinaconazole Impurity 20

Ref: ST-EA-CP-E65031